Joseph S. Zakrzewski - 18 Nov 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph S. Zakrzewski
Issuer symbol
ANTX
Transactions as of
18 Nov 2024
Net transactions value
+$25,046
Form type
4
Filing time
20 Nov 2024, 16:11:58 UTC
Previous filing
21 Jun 2024
Next filing
27 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $19,996 +20,000 +20% $0.9998 118,199 18 Nov 2024 Direct
transaction ANTX Common Stock Purchase $5,050 +5,000 +4.2% $1.01 123,199 19 Nov 2024 Direct
holding ANTX Common Stock 405,880 18 Nov 2024 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.